deferoxamine has been researched along with Anemia, Aplastic in 53 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
Anemia, Aplastic: A form of anemia in which the bone marrow fails to produce adequate numbers of peripheral blood elements.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A number of studies have shown that regular chelation therapy with deferoxamine is effective in patients with secondary hemochromatosis." | 7.69 | [Long-term efficacy of subcutaneous administration of deferoxamine in patients with secondary hemochromatosis]. ( Fujisawa, S; Kobayashi, M; Yano, K, 1996) |
| "Deferoxamine, an iron chelating agent, has been used for the treatment of hemochromatosis for more than 30 years." | 7.69 | [Ocular side effects of deferoxamine therapy in aplastic anemia with transfusion-induced hemochromatosis]. ( Lang, GE; Schicketanz, C; Spraul, CW, 1996) |
| "Iron overload is commonly observed during the course of aplastic anemia (AA), which is believed to aggravate hematopoiesis, cause multiple organ dysfunction, lead to disease progression, and impair quality of life." | 5.48 | Comparison of the effects of deferasirox, deferoxamine, and combination of deferasirox and deferoxamine on an aplastic anemia mouse model complicated with iron overload. ( Hu, H; Liu, W; Wen, X; Wu, D; Ye, B; Zhou, Y, 2018) |
| " Despite the availability of deferoxamine (DFO) in Korea since 1998, data from patients with myelodysplastic syndromes, aplastic anemia, and other BMFS show significant iron overload and damage to the heart and liver." | 4.84 | Iron chelation therapy in the myelodysplastic syndromes and aplastic anemia: a review of experience in South Korea. ( Lee, JW, 2008) |
| " In July 1996, deferoxamine was administered for iron overload." | 4.80 | [Development of arterial thrombus of Mucorales hyphae during deferoxamine therapy in a patient with aplastic anemia in transformation to myelodysplastic syndrome]. ( Kajiguchi, T; Miyata, Y; Saito, M; Takeyama, H, 2000) |
| "A number of studies have shown that regular chelation therapy with deferoxamine is effective in patients with secondary hemochromatosis." | 3.69 | [Long-term efficacy of subcutaneous administration of deferoxamine in patients with secondary hemochromatosis]. ( Fujisawa, S; Kobayashi, M; Yano, K, 1996) |
| "Deferoxamine, an iron chelating agent, has been used for the treatment of hemochromatosis for more than 30 years." | 3.69 | [Ocular side effects of deferoxamine therapy in aplastic anemia with transfusion-induced hemochromatosis]. ( Lang, GE; Schicketanz, C; Spraul, CW, 1996) |
| "Of 89 patients receiving nightly subcutaneous deferoxamine for transfusion-dependent thalassemia major or Diamond-Blackfan anemia, 13 presented with visual loss or deafness of acute onset or both." | 3.67 | Visual and auditory neurotoxicity in patients receiving subcutaneous deferoxamine infusions. ( Buncic, JR; Chew, E; Gallant, T; Harrison, RV; Keenan, N; Logan, W; Mitchell, D; Olivieri, NF; Ricci, G; Skarf, B, 1986) |
| "Iron overload is commonly observed during the course of aplastic anemia (AA), which is believed to aggravate hematopoiesis, cause multiple organ dysfunction, lead to disease progression, and impair quality of life." | 1.48 | Comparison of the effects of deferasirox, deferoxamine, and combination of deferasirox and deferoxamine on an aplastic anemia mouse model complicated with iron overload. ( Hu, H; Liu, W; Wen, X; Wu, D; Ye, B; Zhou, Y, 2018) |
| "He was diagnosed with aplastic anemia at 11-yr of age." | 1.35 | Complete hematopoietic recovery after continuous iron chelation therapy in a patient with severe aplastic anemia with secondary hemochromatosis. ( Han, CW; Park, SJ, 2008) |
| "Myelodysplastic syndromes (MDS) and aplastic anemia (AA) are the most common anemias that require transfusion therapy in Japan." | 1.34 | Retrospective nationwide survey of Japanese patients with transfusion-dependent MDS and aplastic anemia highlights the negative impact of iron overload on morbidity/mortality. ( Harada, M; Kanakura, Y; Murate, T; Nakahata, T; Nakao, S; Okamoto, S; Ozawa, K; Sawada, K; Takatoku, M; Tomonaga, M; Uchiyama, T, 2007) |
| "A 32 year old woman with severe aplastic anaemia required frequent transfusions and consequently developed hyperferrioxaemia (54 microMol/l) and hyperferritinaemia (1,700 ng/ml)." | 1.27 | High dosage desferrioxamine therapy in a female patient with acquired aplastic anaemia and transfusion siderosis. ( Bleyl, H; Breithaupt, H; Graef, V; Guttmann, W; Heckers, H; Jundt, G; Pralle, H, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 38 (71.70) | 18.7374 |
| 1990's | 5 (9.43) | 18.2507 |
| 2000's | 5 (9.43) | 29.6817 |
| 2010's | 5 (9.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, D | 1 |
| Wen, X | 1 |
| Liu, W | 1 |
| Hu, H | 1 |
| Ye, B | 1 |
| Zhou, Y | 1 |
| Banerjee, A | 1 |
| Mifsud, NA | 1 |
| Bird, R | 1 |
| Forsyth, C | 1 |
| Szer, J | 1 |
| Tam, C | 1 |
| Kellner, S | 1 |
| Grigg, A | 1 |
| Motum, P | 1 |
| Bentley, M | 1 |
| Opat, S | 1 |
| Grigoriadis, G | 1 |
| Nijjar, PS | 1 |
| Vongooru, H | 1 |
| Tamene, A | 1 |
| Valeti, U | 1 |
| Masri, C | 1 |
| Lee, JW | 1 |
| Cario, H | 1 |
| Grosse, R | 1 |
| Janssen, G | 1 |
| Jarisch, A | 1 |
| Meerpohl, J | 1 |
| Strauss, G | 1 |
| Shetty, A | 1 |
| Anwar, SQ | 1 |
| Acharya, S | 1 |
| NORMAN, CS | 1 |
| HILDNER, FJ | 2 |
| MONTO, RW | 2 |
| REBUCK, JW | 2 |
| CARLOS, AG | 1 |
| SOARES, AD | 1 |
| KARSTOFT, H | 1 |
| WILKINSON, JF | 1 |
| MOESCHLIN, S | 1 |
| SCHNIDER, U | 1 |
| FIELDING, J | 1 |
| GEVIRTZ, NR | 1 |
| TENDLER, D | 1 |
| LURINSKY, G | 1 |
| WASSERMAN, LR | 1 |
| Mwanda, OW | 1 |
| Otieno, CF | 1 |
| Abdalla, FK | 1 |
| Takatoku, M | 1 |
| Uchiyama, T | 1 |
| Okamoto, S | 1 |
| Kanakura, Y | 1 |
| Sawada, K | 1 |
| Tomonaga, M | 1 |
| Nakao, S | 1 |
| Nakahata, T | 1 |
| Harada, M | 1 |
| Murate, T | 1 |
| Ozawa, K | 1 |
| Park, SJ | 1 |
| Han, CW | 1 |
| Thompson, RB | 1 |
| Owen, DM | 1 |
| Bell, WN | 1 |
| Green, R | 1 |
| Lamon, J | 1 |
| Curran, D | 1 |
| Hehlmann, R | 1 |
| Schmitz, H | 1 |
| Krüger, K | 1 |
| Andres, J | 1 |
| Tillmann, W | 1 |
| König, R | 1 |
| Schröder, K | 1 |
| Schröter, W | 1 |
| Tuschy, U | 1 |
| Schmidt, U | 1 |
| Meinhold, J | 1 |
| Wutke, K | 1 |
| Ambruso, DR | 1 |
| Mahony, BS | 1 |
| Githens, JH | 1 |
| Rhoades, ED | 1 |
| Sidi, Y | 1 |
| Shaklai, M | 1 |
| Liban, E | 1 |
| Pinkhas, J | 1 |
| Janka, GE | 1 |
| Möhring, P | 1 |
| Helmig, M | 1 |
| Haas, RJ | 1 |
| Betke, K | 1 |
| Kobayashi, M | 1 |
| Yano, K | 1 |
| Fujisawa, S | 1 |
| Spraul, CW | 1 |
| Schicketanz, C | 1 |
| Lang, GE | 1 |
| Miyata, Y | 1 |
| Kajiguchi, T | 1 |
| Saito, M | 1 |
| Takeyama, H | 1 |
| Pippard, MJ | 1 |
| Callender, ST | 1 |
| Warner, GT | 1 |
| Weatherall, DJ | 1 |
| Hoffbrand, AV | 1 |
| Gorman, A | 1 |
| Laulicht, M | 1 |
| Garidi, M | 1 |
| Economidou, J | 1 |
| Georgipoulou, P | 1 |
| Hussain, MA | 1 |
| Flynn, DM | 1 |
| Uchida, T | 1 |
| Tanaka, T | 1 |
| Umino, M | 1 |
| Kimura, H | 1 |
| Abe, R | 1 |
| Matsuda, S | 1 |
| Akizuki, T | 1 |
| Kariyone, S | 1 |
| Fujiyama, N | 1 |
| Nakazawa, K | 1 |
| Arnold, H | 1 |
| Wehinger, H | 1 |
| Deus, B | 1 |
| Löhr, GW | 1 |
| Derfus, BA | 1 |
| Csuka, ME | 1 |
| Carrera, GF | 1 |
| Hanson, GA | 1 |
| Smith, RE | 1 |
| Olivieri, NF | 2 |
| Koren, G | 1 |
| Hermann, C | 1 |
| Bentur, Y | 1 |
| Chung, D | 1 |
| Klein, J | 1 |
| St Louis, P | 1 |
| Freedman, MH | 1 |
| McClelland, RA | 1 |
| Templeton, DM | 1 |
| Poot, M | 1 |
| Hoehn, H | 1 |
| Dickerhoff, R | 1 |
| Cohen, AR | 1 |
| Mizanin, J | 1 |
| Schwartz, E | 1 |
| Porfirio, B | 1 |
| Ambroso, G | 1 |
| Giannella, G | 1 |
| Isacchi, G | 1 |
| Dallapiccola, B | 1 |
| Ishitoya, N | 1 |
| Gomibuchi, I | 1 |
| Fujisawa, K | 1 |
| Akatsuka, J | 1 |
| Zdziarska, B | 1 |
| Urasiński, I | 1 |
| Buncic, JR | 1 |
| Chew, E | 1 |
| Gallant, T | 1 |
| Harrison, RV | 1 |
| Keenan, N | 1 |
| Logan, W | 1 |
| Mitchell, D | 1 |
| Ricci, G | 1 |
| Skarf, B | 1 |
| Breithaupt, H | 1 |
| Heckers, H | 1 |
| Pralle, H | 1 |
| Guttmann, W | 1 |
| Bleyl, H | 1 |
| Graef, V | 1 |
| Jundt, G | 1 |
| Vadász, G | 1 |
| Haneda, Y | 1 |
| Chida, A | 1 |
| Sensyu, T | 1 |
| Kurokawa, I | 1 |
| Turbina, NS | 2 |
| Khutsishvili, GE | 1 |
| Soboleva, IuG | 1 |
| Lukens, JN | 1 |
| Neuman, LA | 1 |
| De Castro, S | 1 |
| Herreros, V | 1 |
| Orsini, A | 1 |
| Raybaud, C | 1 |
| Bernard, PJ | 1 |
| Aquaron, R | 1 |
| Passeron, P | 1 |
| Fainshtein, FE | 1 |
| Trubina, NS | 1 |
| Sobaleva, IuG | 1 |
| Rozanova, NS | 1 |
| Voronina, AN | 1 |
4 reviews available for deferoxamine and Anemia, Aplastic
| Article | Year |
|---|---|
Iron chelation therapy in the myelodysplastic syndromes and aplastic anemia: a review of experience in South Korea.
Topics: Anemia, Aplastic; Deferoxamine; Endocrine System; Female; Humans; Iron; Iron Overload; Korea; Liver; | 2008 |
ADVANCES IN TREATMENT OF DISEASES OF THE BLOOD.
Topics: Anemia; Anemia, Aplastic; Anemia, Pernicious; Bone Marrow Transplantation; Deferoxamine; Drug Therap | 1964 |
[Development of arterial thrombus of Mucorales hyphae during deferoxamine therapy in a patient with aplastic anemia in transformation to myelodysplastic syndrome].
Topics: Anemia, Aplastic; Chelating Agents; Deferoxamine; Fatal Outcome; Female; Humans; Iron Overload; Midd | 2000 |
[Use of desferal in treatment of sideroses of different origin. (Literature review)].
Topics: Anemia; Anemia, Aplastic; Anemia, Sideroblastic; Animals; Bile; Child, Preschool; Deferoxamine; Hemo | 1968 |
2 trials available for deferoxamine and Anemia, Aplastic
| Article | Year |
|---|---|
Clinical trial of desferrioxamine entrapped in red cell ghosts.
Topics: Adult; Aged; Anemia; Anemia, Aplastic; Blood Transfusion; Clinical Trials as Topic; Deferoxamine; Er | 1980 |
Comparison of oral iron chelator L1 and desferrioxamine in iron-loaded patients.
Topics: Adolescent; Adult; Anemia, Aplastic; Animals; Blood Transfusion; Child; Cohort Studies; Combined Mod | 1990 |
47 other studies available for deferoxamine and Anemia, Aplastic
| Article | Year |
|---|---|
Comparison of the effects of deferasirox, deferoxamine, and combination of deferasirox and deferoxamine on an aplastic anemia mouse model complicated with iron overload.
Topics: Anemia, Aplastic; Animals; Benzoates; Deferasirox; Deferoxamine; Disease Models, Animal; Drug Therap | 2018 |
The oral iron chelator deferasirox inhibits NF-κB mediated gene expression without impacting on proximal activation: implications for myelodysplasia and aplastic anaemia.
Topics: Anemia, Aplastic; Animals; Benzoates; Bone Marrow Cells; Cell Line; Cells, Cultured; Deferasirox; De | 2015 |
Improvement in Left Ventricular Function Despite No Change in T2* with Iron Chelation in Secondary Hemochromatosis.
Topics: Adult; Anemia, Aplastic; Deferiprone; Deferoxamine; Echocardiography; Hemochromatosis; Humans; Iron | 2015 |
[Guidelines for diagnosis and treatment of secondary iron overload in patients with congenital anemia].
Topics: Anemia, Aplastic; Anemia, Diamond-Blackfan; Anemia, Dyserythropoietic, Congenital; Anemia, Sickle Ce | 2010 |
Aplastic anaemia in pregnancy.
Topics: Anemia, Aplastic; Combined Modality Therapy; Deferoxamine; Female; Humans; Platelet Transfusion; Pre | 2011 |
THE TREATMENT OF IRON OVERLOAD WITH DESFERRIOXAMINE B.
Topics: Anemia; Anemia, Aplastic; Blood Transfusion; Deferoxamine; Humans; Hydroxamic Acids; Iron Chelating | 1964 |
CONGENITAL ERYTHROBLASTIC HYPOPLASIA; TREATMENT OF TRANSFUSION HEMOSIDEROSIS WITH DESFERRIOXAMINE B.
Topics: Anemia; Anemia, Aplastic; Blood Group Incompatibility; Blood Transfusion; Deferoxamine; Hemosiderosi | 1964 |
[THE USE OF DESFERRIOXAMINE IN THE TREATMENT OF HEMOCHROMATOSIS].
Topics: Anemia; Anemia, Aplastic; Blood Chemical Analysis; Body Fluids; Deferoxamine; Hemochromatosis; Hydro | 1964 |
[CONGENITAL HYPOPLASTIC ANEMIA. REVIEW AND REPORT ON A CASE TREATED WITH DESFERRIOXAMINE B].
Topics: Anemia; Anemia, Aplastic; Anemia, Hypoplastic, Congenital; Deferoxamine; Humans; Hydroxamic Acids; I | 1964 |
TREATMENT OF PRIMARY AND SECONDARY HEMOCHROMATOSIS AND ACUTE IRON POISONING WITH A NEW POTENT IRON ELIMINATING AGENT (DESFERRIOXAMINE B-DFOM).
Topics: Anemia; Anemia, Aplastic; Anemia, Hemolytic; Anemia, Macrocytic; Deferoxamine; Guinea Pigs; Heavy Me | 1964 |
DIFFERENTIAL FERRIOXAMINE TEST FOR MEASURING CHELATABLE BODY IRON.
Topics: Anemia; Anemia, Aplastic; Anemia, Hemolytic; Anemia, Iron-Deficiency; Anemia, Pernicious; Deferoxami | 1965 |
CLINICAL STUDIES OF STORAGE IRON WITH DESFERRIOXAMINE.
Topics: Anemia; Anemia, Aplastic; Blood Transfusion; Deferoxamine; Drug Therapy; Feces; Humans; Iron; Urine | 1965 |
Transfusion haemosiderosis inspite of regular use of desferrioxamine: case report.
Topics: Adult; Anemia, Aplastic; Deferoxamine; Fatal Outcome; Female; Hemosiderosis; Humans; Iron Chelating | 2004 |
Retrospective nationwide survey of Japanese patients with transfusion-dependent MDS and aplastic anemia highlights the negative impact of iron overload on morbidity/mortality.
Topics: Adult; Aged; Aged, 80 and over; Anemia, Aplastic; Blood Transfusion; Cause of Death; Deferoxamine; F | 2007 |
Complete hematopoietic recovery after continuous iron chelation therapy in a patient with severe aplastic anemia with secondary hemochromatosis.
Topics: Adolescent; Anemia, Aplastic; Chelation Therapy; Deferoxamine; Erythrocyte Transfusion; Hemochromato | 2008 |
Desferal therapy in iron storage disease.
Topics: Adolescent; Adult; Anemia, Aplastic; Anemia, Sickle Cell; Deferoxamine; Female; Hemochromatosis; Hem | 1967 |
Iron overload in cardiac valvular disease and pure red cell aplasia: treatment with desferrioxamine.
Topics: Anemia, Aplastic; Atrial Fibrillation; Cardiomegaly; Deferoxamine; Female; Hemosiderosis; Humans; Ir | 1984 |
[Transfusion induced hypersiderosis in aplastic anemia--physiopathology and therapeutic aspects].
Topics: Anemia, Aplastic; Deferoxamine; Hemosiderosis; Humans; Infusions, Parenteral; Iron; Transfusion Reac | 1983 |
[Continuous subcutaneous desferrioxamine infusions in patients with hemosiderosis (author's transl)].
Topics: Adolescent; Adult; Anemia, Aplastic; Child; Child, Preschool; Deferoxamine; Hemosiderosis; Humans; I | 1982 |
[Long-term study in congenital refractory anemia and secondary siderosis].
Topics: Adolescent; Anemia, Aplastic; Deferoxamine; Dwarfism; Female; Hemosiderosis; Humans; Hypogonadism; H | 1982 |
Effect of subcutaneous deferoxamine and oral vitamin C on iron excretion in congenital hypoplastic anemia and refractory anemia associated with the 5q-syndrome.
Topics: Administration, Oral; Anemia, Aplastic; Ascorbic Acid; Blood Transfusion; Child; Chromosome Aberrati | 1982 |
Continuous high-dose intravenous desferrioxamine treatment for iron overload.
Topics: Aged; Anemia, Aplastic; Deferoxamine; Erythrocyte Transfusion; Hemosiderosis; Humans; Infusions, Par | 1981 |
Intravenous and subcutaneous desferrioxamine therapy in children with severe iron overload.
Topics: Adolescent; Anemia, Aplastic; Anemia, Sideroblastic; Child; Child, Preschool; Deferoxamine; Hemoside | 1981 |
[Long-term efficacy of subcutaneous administration of deferoxamine in patients with secondary hemochromatosis].
Topics: Aged; Anemia, Aplastic; Deferoxamine; Female; Hemochromatosis; Humans; Injections, Subcutaneous; Mal | 1996 |
[Ocular side effects of deferoxamine therapy in aplastic anemia with transfusion-induced hemochromatosis].
Topics: Anemia, Aplastic; Blood Transfusion; Child; Deferoxamine; Electroretinography; Evoked Potentials, Vi | 1996 |
Iron absorption in iron-loading anaemias: Effect of subcutaneous desferrioxamine infusions.
Topics: Administration, Oral; Adolescent; Adult; Anemia, Aplastic; Anemia, Sideroblastic; Ascorbic Acid; Bin | 1977 |
Improvement in iron status and liver function in patients with transfusional iron overload with long-term subcutaneous desferrioxamine.
Topics: Adolescent; Adult; Aged; Anemia, Aplastic; Anemia, Sideroblastic; Aspartate Aminotransferases; Child | 1979 |
[Serum ferritin concentration as an evaluation of storage iron (author's transl)].
Topics: Adult; Anemia, Aplastic; Deferoxamine; Female; Ferritins; Humans; Iron; Male; Middle Aged | 1979 |
[The effect of desferrioxamine on the treatment of transfusion hemosiderosis--with special reference to the method of its administration (authors' transl)].
Topics: Adult; Aged; Anemia, Aplastic; Deferoxamine; Female; Hemosiderosis; Humans; Iron; Male; Transfusion | 1977 |
[Controlled desferrioxamine treatment of congenital anaemia and transfusion siderosis (author's transl)].
Topics: Adolescent; Anemia, Aplastic; Child; Deferoxamine; Erythrocytes, Abnormal; Humans; Iron; Male; Sider | 1978 |
Bone remodelling after growth factor and cyclosporine A therapy for aplastic anemia.
Topics: Adolescent; Anemia, Aplastic; Antilymphocyte Serum; Bone and Bones; Cyclosporins; Deferoxamine; Fema | 1991 |
Partial correction of chromosome instability in Fanconi anemia by desferrioxamine.
Topics: Anemia, Aplastic; Chromosome Aberrations; Deferoxamine; Fanconi Anemia; Humans; Lymphocytes | 1990 |
Acute aphasia and loss of vision with desferrioxamine overdose.
Topics: Anemia, Aplastic; Aphasia; Blindness; Child; Deferoxamine; Dose-Response Relationship, Drug; Female; | 1987 |
Rapid removal of excessive iron with daily, high-dose intravenous chelation therapy.
Topics: Adolescent; Adult; Anemia, Aplastic; Anemia, Sickle Cell; Catheterization, Central Venous; Deferoxam | 1989 |
Partial correction of chromosome instability in Fanconi anemia by desferrioxamine.
Topics: Anemia, Aplastic; Cells, Cultured; Chromosome Aberrations; Chromosomes, Human; Deferoxamine; Epoxy C | 1989 |
[Effect of continuous subcutaneous infusion of deferoxamine in a boy with congenital hypoplastic anemia].
Topics: Anemia, Aplastic; Child, Preschool; Deferoxamine; Drug Evaluation; Erythrocyte Transfusion; Hemoside | 1988 |
[Subcutaneous administration of deferoxamine in a patient with panmyelopathy and post-transfusion hemosiderosis].
Topics: Adult; Anemia, Aplastic; Deferoxamine; Hemosiderosis; Humans; Injections, Subcutaneous; Male; Transf | 1987 |
Visual and auditory neurotoxicity in patients receiving subcutaneous deferoxamine infusions.
Topics: Adolescent; Adult; Age Factors; Anemia, Aplastic; Audiometry; Child; Child, Preschool; Color Vision | 1986 |
High dosage desferrioxamine therapy in a female patient with acquired aplastic anaemia and transfusion siderosis.
Topics: Adult; Anemia, Aplastic; Bone Marrow; Deferoxamine; Feces; Female; Ferritins; Humans; Iron; Siderosi | 1986 |
[A case of Diamond-Blackfan anemia: Experiences of 10-year follow-up study].
Topics: Adolescent; Anemia, Aplastic; Biopsy; Blood Transfusion; Child; Child, Preschool; Deferoxamine; Eryt | 1974 |
[A case of pure red cell aplasia].
Topics: Adult; Anemia, Aplastic; Blood Transfusion; Deferoxamine; Female; Humans | 1973 |
[Effectiveness of Desferal in diseases occurring simultaneously with hypersiderosis].
Topics: Adult; Anemia, Aplastic; Deferoxamine; Humans; Middle Aged; Siderosis | 1973 |
EXcretion and distribution of iron during chronic deferoxamine therapy.
Topics: Anemia, Aplastic; Bone Marrow; Bone Marrow Examination; Child; Chromium Isotopes; Deferoxamine; Foli | 1971 |
[Ferrokinetic data in 11 cases of idiopathic aplastic anemia].
Topics: Adult; Anemia, Aplastic; Deferoxamine; Humans; Iron; Middle Aged | 1970 |
[Current status of treatments with desferrioxamine B in post-transfusion hypersiderosis in children].
Topics: Adolescent; Anemia, Aplastic; Anemia, Hemolytic; Child; Child, Preschool; Deferoxamine; Female; Hemo | 1967 |
Congenital erythroblastic hypoplasia. Treatment of transfusion hemosiderosis with desferrioxamine B.
Topics: Adolescent; Adult; Anemia, Aplastic; Child; Child, Preschool; Deferoxamine; Hemosiderosis; Humans; I | 1968 |
[Use of desferal and some data on hemosiderosis in hypo- and aplastic anemias].
Topics: Acute Disease; Adolescent; Adult; Anemia, Aplastic; Chronic Disease; Deferoxamine; Female; Hemochrom | 1968 |